Pharmaceuticals October 15, 2025

Labelling Requirements

OMC Admin

OMC AdminContent Writer

Labelling Requirements
Economic OperatorSwissEUUK
AR/RP

CH REP on the product label. Name and Address of the registered place of business.

OMC Swiss AR Address:

OMCS Medical Gmbh

C/O Mr Wilhelm Gudelow Aegeristrasse 5 6300 Zug

EU AR on the product label. Name and Address of the registered place of business.

OMC EU AR Address:

OMC NI Medical Ltd

Unit-763 Moat House Business Centre,

54 Bloomfield Avenue Belfast,

Northern Ireland BT5 5AD

UK Responsible person on the product label for UKCA-marked devices only. Name and Address of the registered place of business deadline 31/12/2027

No specific symbol required

OMC UK RP Address:

OMC Medical Limited, Planet House,

North heath lane, Horsham RH12 5QE.

ImporterCH Importer on the product, product packaging or a document enclosed with the product.

Importer on a device or its packaging or in a document accompanying the device.

 

No Labelling requirement at this stage.
Compliance symbolWhat is CE Marking? - CE Mark Certification vs. Self Declaration | ASQWhat is CE Marking? - CE Mark Certification vs. Self Declaration | ASQ

Dual labelling is allowed in the UK so that you can have both CE and UKCA marking on your products.


Enjoyed this article?

Share it with your network and help others discover great content.

Related Blogs

Stay updated with the latest regulatory updates and insights

A Strategic Guide to Pharmaceutical Product Registration in Senegal by OMC Medical

November 07, 2025

A Strategic Guide to Pharmaceutical Product Registration in Senegal by OMC Medical
Learn More
Navigating Biologic Product Registration in Thailand: TFDA Requirements, Procedures, and Validation Process

October 14, 2025

Navigating Biologic Product Registration in Thailand: TFDA Requirements, Procedures, and Validation Process
Learn More
Overhauling Drug Registration: The Indonesian Food and Drug Authority’s Progressive Amendment

October 14, 2025

Overhauling Drug Registration: The Indonesian Food and Drug Authority’s Progressive Amendment
Learn More
LinkedIn Message on LinkedIn WhatsApp Start WhatsApp chat Call Call us